These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 19879055)
21. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Jänne PA; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Taylor L; Ashland J; Ye Z; Monberg MJ; Obasaju CK Clin Lung Cancer; 2005 Jul; 7(1):40-6. PubMed ID: 16098243 [TBL] [Abstract][Full Text] [Related]
22. Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer. Dickgreber NJ; Fink TH; Latz JE; Hossain AM; Musib LC; Thomas M Clin Cancer Res; 2009 Jan; 15(1):382-9. PubMed ID: 19118069 [TBL] [Abstract][Full Text] [Related]
23. A retrospective study of chemotherapy with and without pemetrexed in malignant pleural mesothelioma. Higashiguchi M; Suzuki H; Hirashima T; Kobayashi M; Goya S; Okamoto N; Matsuura Y; Tamiya M; Morishita N; Tsumori T; Kawase I Anticancer Res; 2012 Feb; 32(2):609-13. PubMed ID: 22287752 [TBL] [Abstract][Full Text] [Related]
24. [A case of malignant pleural mesothelioma that responded to cisplatin plus pemetrexed rechallenge]. Shukuya T; Takahashi T; Nakamura Y; Yamamoto N Gan To Kagaku Ryoho; 2010 Mar; 37(3):487-90. PubMed ID: 20332689 [TBL] [Abstract][Full Text] [Related]
28. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial. Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752 [TBL] [Abstract][Full Text] [Related]
29. Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option? Li L; Razak AR; Hughes A Lung Cancer; 2009 May; 64(2):207-10. PubMed ID: 18926592 [TBL] [Abstract][Full Text] [Related]
30. Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program. Taylor P; Castagneto B; Dark G; Marangolo M; Scagliotti GV; van Klaveren RJ; Labianca R; Serke M; Schuette W; van Meerbeeck JP; Heigener D; Liu Y; Adachi S; Blatter J; von Pawel J J Thorac Oncol; 2008 Jul; 3(7):764-71. PubMed ID: 18594323 [TBL] [Abstract][Full Text] [Related]
31. Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study. Katirtzoglou N; Gkiozos I; Makrilia N; Tsaroucha E; Rapti A; Stratakos G; Fountzilas G; Syrigos KN Clin Lung Cancer; 2010 Jan; 11(1):30-5. PubMed ID: 20085865 [TBL] [Abstract][Full Text] [Related]
32. Current concepts in chemotherapy for malignant pleural mesothelioma. Sørensen JB Clin Respir J; 2008 Apr; 2(2):74-9. PubMed ID: 20298310 [TBL] [Abstract][Full Text] [Related]
33. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma]. Wang YY; Zhang H; Bai H; Wang SH; Wu MN; An TT; Zhao J; Zhuo ML; Duan JC; Wang ZJ; Wang J Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):162-8. PubMed ID: 23856136 [TBL] [Abstract][Full Text] [Related]
34. Malignant pleural mesothelioma: current treatments and emerging drugs. Belli C; Fennell D; Giovannini M; Gaudino G; Mutti L Expert Opin Emerg Drugs; 2009 Sep; 14(3):423-37. PubMed ID: 19552609 [TBL] [Abstract][Full Text] [Related]
35. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. Scagliotti GV; Shin DM; Kindler HL; Vasconcelles MJ; Keppler U; Manegold C; Burris H; Gatzemeier U; Blatter J; Symanowski JT; Rusthoven JJ J Clin Oncol; 2003 Apr; 21(8):1556-61. PubMed ID: 12697881 [TBL] [Abstract][Full Text] [Related]
36. Multimodality therapy in mesothelioma: role of chemotherapy. Vogelzang NJ Thorac Surg Clin; 2004 Nov; 14(4):531-42. PubMed ID: 15559060 [TBL] [Abstract][Full Text] [Related]
37. Chemotherapy for malignant pleural mesothelioma: past results and recent developments. Tomek S; Manegold C Lung Cancer; 2004 Aug; 45 Suppl 1():S103-19. PubMed ID: 15261443 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patients. Nakagawa K; Yamazaki K; Kunitoh H; Hida T; Gemba K; Shinkai T; Ichinose Y; Adachi S; Nambu Y; Saijo N; Fukuoka M Jpn J Clin Oncol; 2008 May; 38(5):339-46. PubMed ID: 18434338 [TBL] [Abstract][Full Text] [Related]
39. Life after first-line chemotherapy in malignant pleural mesothelioma: a North-East England experience. Steer J; Bough G; Razak AR; Meachery GJ; Hughes A Clin Oncol (R Coll Radiol); 2010 Apr; 22(3):231-5. PubMed ID: 20346340 [TBL] [Abstract][Full Text] [Related]